JANUS HENDERSON GROUP PLC - JANUX THERAPEUTICS INC ownership

JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 48 filers reported holding JANUX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of JANUX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,823,593
-16.8%
2,067,468
-2.0%
0.01%
-12.5%
Q2 2023$25,031,210
+10.7%
2,109,338
+12.9%
0.02%
+6.7%
Q1 2023$22,611,527
-6.5%
1,869,076
+1.7%
0.02%
-11.8%
Q4 2022$24,173,460
-9.0%
1,837,791
-53.1%
0.02%
-15.0%
Q3 2022$26,572,546
+2.3%
3,920,088
+84.2%
0.02%
+11.1%
Q2 2022$25,966,000
-22.6%
2,127,797
-9.0%
0.02%
+12.5%
Q1 2022$33,542,000
-28.0%
2,339,146
-2.6%
0.02%
-15.8%
Q4 2021$46,558,000
-9.4%
2,400,893
-0.6%
0.02%
-13.6%
Q3 2021$51,375,000
-20.4%
2,416,404
-9.4%
0.02%
-21.4%
Q2 2021$64,522,0002,668,2070.03%
Other shareholders
JANUX THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RA Capital Management 8,670,644$187,546,0002.60%
5AM Venture Management, LLC 446,266$9,653,0001.96%
Samsara BioCapital, LLC 411,871$8,909,0001.40%
EcoR1 Capital, LLC 1,411,975$30,541,0001.06%
BVF INC/IL 1,017,314$22,005,0000.86%
Orbimed Advisors 3,466,386$74,978,0000.82%
Logos Global Management LP 247,122$4,811,0000.35%
Woodline Partners LP 300,031$6,490,0000.11%
Parkwood LLC 20,777$449,0000.05%
JANUS HENDERSON GROUP PLC 2,416,404$51,375,0000.02%
View complete list of JANUX THERAPEUTICS INC shareholders